These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3203409

  • 1. Quantitation of interaction between cytochrome P-450scc and adrenodoxin--analysis in the median UV-region by second derivative spectroscopy.
    Shkumatov VM, Smettan G, Ristau O, Rein H, Ruckpaul K, Chaschin VL, Akhrem AA.
    Chem Biol Interact; 1988; 68(1-2):71-83. PubMed ID: 3203409
    [Abstract] [Full Text] [Related]

  • 2. Participation of the membrane in the side chain cleavage of cholesterol. Reconstitution of cytochrome P-450scc into phospholipid vesicles.
    Seybert DW, Lancaster JR, Lambeth JD, Kamin H.
    J Biol Chem; 1979 Dec 10; 254(23):12088-98. PubMed ID: 500697
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of electron transfer from adrenodoxin to cytochrome P-450scc by chemical modification with pyridoxal 5'-phosphate: identification of adrenodoxin-binding site of cytochrome P-450scc.
    Tsubaki M, Iwamoto Y, Hiwatashi A, Ichikawa Y.
    Biochemistry; 1989 Aug 22; 28(17):6899-907. PubMed ID: 2819041
    [Abstract] [Full Text] [Related]

  • 4. The formation of binary and ternary complexes of cytochrome P-450scc with adrenodoxin and adrenodoxin reductase.adrenodoxin complex. The implication in ACTH function.
    Kido T, Kimura T.
    J Biol Chem; 1979 Dec 10; 254(23):11806-15. PubMed ID: 227881
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of protein-protein interactions in an enzymatically complete cholesterol hydroxylating system].
    Radiuk VG, Shkumatov VM, Chashchin VL, Akhrem AA.
    Biokhimiia; 1982 Nov 10; 47(11):1792-801. PubMed ID: 7150671
    [Abstract] [Full Text] [Related]

  • 6. Effects of phospholipid and detergent on the substrate specificity of adrenal cytochrome P-450scc. Substrate binding and kinetics of cholesterol side chain oxidation.
    Greenfield NJ, Gerolimatos B, Szwergold BS, Wolfson AJ, Prasad VV, Lieberman S.
    J Biol Chem; 1981 May 10; 256(9):4407-17. PubMed ID: 6260797
    [Abstract] [Full Text] [Related]

  • 7. Cross-linking studies of the cholesterol hydroxylation system from bovine adrenocortical mitochondria.
    Turko IV, Adamovich TB, Kirillova NM, Usanov SA, Chashchin VL.
    Biochim Biophys Acta; 1989 Jun 13; 996(1-2):37-42. PubMed ID: 2736257
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the immunochemical properties of human placental and bovine adrenal cholesterol side-chain cleavage enzyme complex.
    Usanov SA, Honkakoski P, Lang MA, Pasanen M, Pelkonen O, Raunio H.
    Biochim Biophys Acta; 1989 Oct 05; 998(2):189-95. PubMed ID: 2790061
    [Abstract] [Full Text] [Related]

  • 9. Cytochrome P-450scc induces vesicle aggregation through a secondary interaction at the adrenodoxin binding sites (in competition with protein exchange.
    Dhariwal MS, Kowluru RA, Jefcoate CR.
    Biochemistry; 1991 May 21; 30(20):4940-9. PubMed ID: 2036362
    [Abstract] [Full Text] [Related]

  • 10. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta.
    Tuckey RC, Woods ST, Tajbakhsh M.
    Eur J Biochem; 1997 Mar 15; 244(3):835-9. PubMed ID: 9108254
    [Abstract] [Full Text] [Related]

  • 11. Active complex between adrenodoxin reductase and adrenodoxin in the cytochrome P-450scc reduction reaction.
    Hara T, Kimura T.
    J Biochem; 1989 Apr 15; 105(4):601-5. PubMed ID: 2503499
    [Abstract] [Full Text] [Related]

  • 12. Modification of histidine 56 in adrenodoxin with diethyl pyrocarbonate inhibited the interaction with cytochrome P-450scc and adrenodoxin reductase.
    Miura S, Tomita S, Ichikawa Y.
    J Biol Chem; 1991 Oct 15; 266(29):19212-6. PubMed ID: 1918039
    [Abstract] [Full Text] [Related]

  • 13. Formation of a cytochrome P-450scc-adrenodoxin complex.
    Katagiri M, Takikawa O, Sato H, Suhara K.
    Biochem Biophys Res Commun; 1977 Jul 25; 77(2):804-9. PubMed ID: 561606
    [No Abstract] [Full Text] [Related]

  • 14. Phospholipid vesicle-reconstituted cytochrome P-450SCC. Mutually facilitated binding of cholesterol and adrenodoxin.
    Lambeth JD, Seybert DW, Kamin H.
    J Biol Chem; 1980 Jan 10; 255(1):138-43. PubMed ID: 7350146
    [No Abstract] [Full Text] [Related]

  • 15. 22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
    Lambeth JD.
    Mol Pharmacol; 1983 May 10; 23(3):743-7. PubMed ID: 6688121
    [Abstract] [Full Text] [Related]

  • 16. Conformational change of the heme moiety of the ferrous cytochrome P-450scc-phenyl isocyanide complex upon binding of reduced adrenodoxin.
    Tsubaki M, Hiwatashi A, Ichikawa Y.
    Biochemistry; 1989 Dec 12; 28(25):9777-84. PubMed ID: 2611261
    [Abstract] [Full Text] [Related]

  • 17. 3-Methoxybenzidine: a potent inhibitor of cholesterol side chain cleavage cytochrome P-450.
    Duval JF, Vickery LE.
    Steroids; 1980 Oct 12; 36(4):473-81. PubMed ID: 7444997
    [Abstract] [Full Text] [Related]

  • 18. The side-chain cleavage of cholesterol sulfate--I. The effect of adrenodoxin on the binding of cholesterol sulfate to cytochrome P-450scc.
    Greenfield NJ, Gerolimatos B.
    J Steroid Biochem; 1985 Jun 12; 22(6):809-16. PubMed ID: 4021484
    [Abstract] [Full Text] [Related]

  • 19. Electron paramagnetic resonance study of ferrous cytochrome P-450scc-nitric oxide complexes: effects of 20(R),22(R)-dihydroxycholesterol and reduced adrenodoxin.
    Tsubaki M, Hiwatashi A, Ichikawa Y, Fujimoto Y, Ikekawa N, Hori H.
    Biochemistry; 1988 Jun 28; 27(13):4856-62. PubMed ID: 2844242
    [Abstract] [Full Text] [Related]

  • 20. [Interaction between cytochrome P-450scc and adrenodoxin in solution under effects of low spin effectors].
    Radiuk VG, Shkumatov VM, Chashchin VL, Akhrema AA.
    Biokhimiia; 1982 Oct 28; 47(10):1700-9. PubMed ID: 7171649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.